Over 1000 clinical professionals will be gathering at Partnerships in Clinical Trials Europe in Amsterdam next week to discuss the latest innovations, make new connections and catch up with old friends.
The event is also a chance to recognize an industry pioneer who has had a major impact on the world of clinical trials over their career, who has changed the direction the industry is moving in and left a legacy. The winner of the prestigious PCT Lifetime Achievement Award in association with mdgroup will be announced at the end of the first day and we can now reveal the shortlist below.
In its third year, the prestigious award went to Jean Edwards, Procurement Director for Europe, Australia & Japan at Eli Lilly, last year. Back in 2015, it was Professor Kenneth Getz who took the inaugural prize for his work as Director and Associate Professor at Tufts Center for the Study of Drug Development. One of the following worthy nominees will take home this year’s award:
Dr Steven Anderson, Chief Scientific Officer at Covance, USA
“Dr Steven Anderson is the Chief Scientific Officer of Covance. Prior to the CSO role for Covance, he has served in a variety of scientific, technical and operational roles within LabCorp organization. During his 25-year tenure in LabCorp these positions have included Director of Operations for the Center for Molecular Biology and Pathology (CMBP), Director of Operations for ViroMed Laboratories, Director of Operations for Monogram Biosciences, Director of Operations for Integrated Oncology and Genetics, National Director of Research and Development, and Global Head of LabCorp Clinical Trials.
Dr Anderson is a member of a variety of professional societies including the American Association for Cancer Research, the American Society of Clinical Oncology and the Association for Molecular Pathology. His research interests are in the development and applications for molecular diagnostics, including several recent examples of companion diagnostics currently in use for patient management. He has authored more than 175 articles and abstracts published in a wide range of prestigious journals.”
Estrella Garcia, Director Global Clinical Operations, R&D at Almirall, Spain
“Ms Garcia began her ‘scientific odyssey’ at the University of Navarra, Spain, where she gained a PhD in Genetic Toxicology. She joined Almirall as a Clinical Research Scientist, and has amassed a 25-year career, always in the Clinical Development Arena. She is responsible for clinical trials worldwide, from Phase I to Phase IV, with a strategic focus on keeping only core competencies in house and measuring the delivery of the strategic partner by means of KPIs and quality of the deliverables. In this capacity Ms Garcia has worked with dozens of CROs and service providers, and has driven risk based monitoring and outsourcing.
She has led multiple product registrations including the $2 billion deal with AstraZeneca for Almirall's respiratory franchise. Adapting and pioneering industry change as an early adopter, especially with technology, enabling smarter and more efficient clinical trial execution. A true voice for partnership across the industry, offering ideas and insights, and generously providing the benefit of her experience to colleagues looking for constant improvement."
Dr Greg Koski, Chairman, Co-Founder and President/CEO at ACRES and Associate Professor of Anesthesia at Massachusetts General Hospital, Harvard Medical School, USA
"Dr Greg Koski, President, CEO and co-founder of ACRES, the Alliance for Clinical Research Excellence and Safety, was named among this year's 100 most inspiring leaders in the health sciences by PharmaVoice, a leading industry publication. The PharmaVoice 100 recognizes individuals whose contributions and vision have driven change and improved performance in the health sciences and drug development domains. Dr Koski was recognized for his visionary leadership at ACRES, a multi-sector, non-profit public interest collaborative building a comprehensive integrated global system to enhance quality and safety while accelerating innovation.”
Patricia Leuchten, Founder and CEO at The Avoca Group, USA
“Patricia Leuchten has more than 25 years of experience in the pharmaceutical industry and is a leading authority on global clinical outsourcing and strategic alliances.
In 1999, Ms Leuchten founded The Avoca Group, a consulting and research firm specializing in clinical outsourcing, alliance management and quality management in outsourced clinical trials. The Avoca Group has played an important role in the industry as the first consulting firm to track trends in clinical outsourcing and to measure the health of relationships between sponsors and CROs.
Ms Leuchten launched the Avoca Quality Consortium in 2011 to encourage the sharing of leading practices and to bring sponsors and CROs into greater alignment. Since its inception, the rapidly growing Consortium community has advanced collaboration on improving quality, mitigating risk and increasing efficiency in outsourced clinical trials.”
The PCT Lifetime Achievement Award 2017 in association with mdgroup will be announced and presented to the winner at 5.15pm on Tuesday 28 November in the plenary hall at Partnerships in Clinical Trials Europe.